Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Joseph Schwartz is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/25/2025 | MAZE | Buy Now | Maze Therapeutics | $11.49 | 143.69% | Joseph Schwartz50% | → $28 | Initiates | → Outperform | Get Alert |
| 10/11/2024 | TVTX | Buy Now | Travere Therapeutics | $20.12 | 98.81% | Joseph Schwartz50% | $20 → $40 | Maintains | Outperform | Get Alert |
| 10/08/2024 | TVTX | Buy Now | Travere Therapeutics | $20.12 | -0.6% | Joseph Schwartz50% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 09/19/2024 | APLT | Buy Now | Applied Therapeutics | $0.52 | 2592.31% | Joseph Schwartz50% | $11 → $14 | Maintains | Outperform | Get Alert |
| 09/12/2024 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 32.45% | Joseph Schwartz50% | → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/03/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | — | Joseph Schwartz50% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 06/24/2024 | SLDB | Buy Now | Solid Biosciences | $4.95 | 142.42% | Joseph Schwartz50% | $12 → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 06/20/2024 | MREO | Buy Now | Mereo BioPharma Group | $2.53 | 216.21% | Joseph Schwartz50% | $6 → $8 | Maintains | Outperform | Get Alert |
| 03/18/2024 | RGLS | Buy Now | Regulus Therapeutics | $1.33 | 351.13% | Joseph Schwartz50% | → $6 | Initiates | → Outperform | Get Alert |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $0.33 | 514.06% | Joseph Schwartz50% | $9 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/22/2024 | APLT | Buy Now | Applied Therapeutics | $0.52 | 2207.69% | Joseph Schwartz50% | → $12 | Initiates | → Outperform | Get Alert |
| 02/13/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 403.6% | Joseph Schwartz50% | $23 → $7 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/09/2024 | SYBX | Buy Now | Synlogic | $1.29 | -22.48% | Joseph Schwartz50% | → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/15/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | Joseph Schwartz50% | → $10 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/08/2023 | SPRB | Buy Now | Spruce Biosciences | $0.33 | 2663.28% | Joseph Schwartz50% | $3 → $9 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/18/2023 | SELB | Buy Now | Selecta Biosciences | — | — | Joseph Schwartz50% | → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/15/2023 | DSGN | Buy Now | Design Therapeutics | $4.81 | 24.74% | Joseph Schwartz50% | → $6 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/13/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | Joseph Schwartz50% | $44 → $40 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/12/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Joseph Schwartz50% | $80 → $115 | Upgrade | Market Perform → Outperform | Get Alert |
| 03/17/2023 | PTCT | Buy Now | PTC Therapeutics | $55.25 | -13.12% | Joseph Schwartz50% | → $48 | Initiates | → Market Perform | Get Alert |
| 02/03/2023 | PHVS | Buy Now | Pharvaris | $15.96 | 12.78% | Joseph Schwartz50% | $20 → $18 | Maintains | Outperform | Get Alert |
| 02/03/2023 | KALV | Buy Now | KalVista Pharma | $12.47 | 60.38% | Joseph Schwartz50% | $30 → $20 | Maintains | Outperform | Get Alert |
| 02/03/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $33.70 | 0.89% | Joseph Schwartz50% | $33 → $34 | Maintains | Market Perform | Get Alert |
| 02/03/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 81.69% | Joseph Schwartz50% | $122 → $130 | Maintains | Outperform | Get Alert |
| 01/20/2023 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | 115.92% | Joseph Schwartz50% | → $160 | Reiterates | → Outperform | Get Alert |
| 01/17/2023 | ASND | Buy Now | Ascendis Pharma | $164.65 | -1% | Joseph Schwartz50% | $148 → $163 | Maintains | Outperform | Get Alert |
| 12/27/2022 | AMTI | Buy Now | Applied Molecular | — | — | Joseph Schwartz50% | $15 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/09/2022 | DSGN | Buy Now | Design Therapeutics | $4.81 | 357.38% | Joseph Schwartz50% | $30 → $22 | Maintains | Outperform | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $1.49 | 571.14% | Joseph Schwartz50% | $15 → $10 | Maintains | Outperform | Get Alert |
| 11/14/2022 | ASND | Buy Now | Ascendis Pharma | $164.65 | -10.11% | Joseph Schwartz50% | $168 → $148 | Maintains | Outperform | Get Alert |
| 11/14/2022 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 1698.56% | Joseph Schwartz50% | $27 → $25 | Maintains | Outperform | Get Alert |
| 11/10/2022 | SLDB | Buy Now | Solid Biosciences | $4.95 | 21.21% | Joseph Schwartz50% | $1 → $6 | Maintains | Market Perform | Get Alert |
| 11/10/2022 | PEPG | Buy Now | PepGen | $2.22 | 1386.49% | Joseph Schwartz50% | $40 → $33 | Maintains | Outperform | Get Alert |
| 11/10/2022 | MREO | Buy Now | Mereo BioPharma Group | $2.53 | 58.1% | Joseph Schwartz50% | $8 → $4 | Maintains | Outperform | Get Alert |
| 11/08/2022 | AMTI | Buy Now | Applied Molecular | — | — | Joseph Schwartz50% | $21 → $15 | Maintains | Outperform | Get Alert |
| 11/04/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.23 | 45.81% | Joseph Schwartz50% | $17 → $12 | Maintains | Outperform | Get Alert |
| 11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 177.92% | Joseph Schwartz50% | $115 → $108 | Maintains | Outperform | Get Alert |
| 10/27/2022 | INSM | Buy Now | Insmed | $76.99 | -35.06% | Joseph Schwartz50% | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/20/2022 | TVTX | Buy Now | Travere Therapeutics | $20.12 | 88.87% | Joseph Schwartz50% | $45 → $38 | Maintains | Outperform | Get Alert |
| 10/17/2022 | SLDB | Buy Now | Solid Biosciences | $4.95 | -79.8% | Joseph Schwartz50% | $180 → $15 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/17/2022 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | 95.68% | Joseph Schwartz50% | $126 → $145 | Maintains | Outperform | Get Alert |
| 10/05/2022 | KALV | Buy Now | KalVista Pharma | $12.47 | 140.58% | Joseph Schwartz50% | $45 → $30 | Maintains | Outperform | Get Alert |
| 09/14/2022 | PHVS | Buy Now | Pharvaris | $15.96 | 25.31% | Joseph Schwartz50% | $25 → $20 | Maintains | Outperform | Get Alert |
| 08/23/2022 | PHVS | Buy Now | Pharvaris | $15.96 | 56.64% | Joseph Schwartz50% | $45 → $25 | Maintains | Outperform | Get Alert |
| 08/11/2022 | ASND | Buy Now | Ascendis Pharma | $164.65 | 2.03% | Joseph Schwartz50% | $174 → $168 | Maintains | Outperform | Get Alert |
| 08/05/2022 | TVTX | Buy Now | Travere Therapeutics | $20.12 | 123.66% | Joseph Schwartz50% | $42 → $45 | Maintains | Outperform | Get Alert |
| 08/05/2022 | CCXI | Buy Now | ChemoCentryx | — | — | Joseph Schwartz50% | $64 → $52 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/04/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 70.51% | Joseph Schwartz50% | $115 → $122 | Maintains | Outperform | Get Alert |
| 07/08/2022 | KALV | Buy Now | KalVista Pharma | $12.47 | 260.87% | Joseph Schwartz50% | $51 → $45 | Maintains | Outperform | Get Alert |
| 06/06/2022 | SELB | Buy Now | Selecta Biosciences | — | — | Joseph Schwartz50% | → $7 | Initiates | → Outperform | Get Alert |
| 05/31/2022 | PEPG | Buy Now | PepGen | $2.22 | 1701.8% | Joseph Schwartz50% | → $40 | Initiates | → Outperform | Get Alert |
| 05/26/2022 | CRNX | Buy Now | Crinetics Pharmaceuticals | $34.18 | 14.1% | Joseph Schwartz50% | $36 → $39 | Maintains | Outperform | Get Alert |
| 05/23/2022 | KDNY | Buy Now | Chinook Therapeutics | — | — | Joseph Schwartz50% | $38 → $44 | Maintains | Outperform | Get Alert |
| 05/20/2022 | AMTI | Buy Now | Applied Molecular | — | — | Joseph Schwartz50% | $60 → $21 | Maintains | Outperform | Get Alert |
| 05/12/2022 | IFRX | Buy Now | InflaRx | $1.24 | 222.63% | Joseph Schwartz50% | $6 → $4 | Maintains | Outperform | Get Alert |
| 05/12/2022 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | 13.08% | Joseph Schwartz50% | $34 → $30 | Maintains | Outperform | Get Alert |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $164.65 | 5.68% | Joseph Schwartz50% | $193 → $174 | Maintains | Outperform | Get Alert |
| 05/11/2022 | GOSS | Buy Now | Gossamer Bio | $1.49 | 906.71% | Joseph Schwartz50% | $16 → $15 | Maintains | Outperform | Get Alert |
| 05/11/2022 | RNA | Buy Now | Avidity Biosciences | $30.48 | 64.04% | Joseph Schwartz50% | $53 → $50 | Maintains | Outperform | Get Alert |
| 05/10/2022 | DSGN | Buy Now | Design Therapeutics | $4.81 | 523.7% | Joseph Schwartz50% | $36 → $30 | Maintains | Outperform | Get Alert |
| 05/10/2022 | AMTI | Buy Now | Applied Molecular | — | — | Joseph Schwartz50% | $74 → $60 | Maintains | Outperform | Get Alert |
| 05/06/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 195.93% | Joseph Schwartz50% | $178 → $115 | Maintains | Outperform | Get Alert |
| 05/05/2022 | PTGX | Buy Now | Protagonist Therapeutics | $54.52 | -44.97% | Joseph Schwartz50% | $50 → $30 | Maintains | Outperform | Get Alert |
| 05/03/2022 | QURE | Buy Now | uniQure | $13.31 | 320.73% | Joseph Schwartz50% | $71 → $56 | Maintains | Outperform | Get Alert |
| 04/28/2022 | SLDB | Buy Now | Solid Biosciences | $4.95 | 203.03% | Joseph Schwartz50% | $180 → $225 | Maintains | Outperform | Get Alert |
| 04/06/2022 | IMRA | Buy Now | Imara | — | — | Joseph Schwartz50% | $124 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/30/2022 | PHVS | Buy Now | Pharvaris | $15.96 | 181.95% | Joseph Schwartz50% | $50 → $45 | Maintains | Outperform | Get Alert |
| 03/25/2022 | IFRX | Buy Now | InflaRx | $1.24 | 383.95% | Joseph Schwartz50% | $8 → $6 | Maintains | Outperform | Get Alert |
| 03/24/2022 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | Joseph Schwartz50% | $250 → $150 | Maintains | Outperform | Get Alert |
| 03/18/2022 | SYBX | Buy Now | Synlogic | $1.29 | 520.16% | Joseph Schwartz50% | $165 → $120 | Maintains | Outperform | Get Alert |
| 03/16/2022 | SPRB | Buy Now | Spruce Biosciences | $0.33 | 821.09% | Joseph Schwartz50% | $5 → $3 | Maintains | Market Perform | Get Alert |
| 03/16/2022 | IMRA | Buy Now | Imara | — | — | Joseph Schwartz50% | $148 → $124 | Maintains | Outperform | Get Alert |
| 03/15/2022 | ASND | Buy Now | Ascendis Pharma | $164.65 | 17.22% | Joseph Schwartz50% | $190 → $193 | Maintains | Outperform | Get Alert |
| 03/08/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.23 | 167.31% | Joseph Schwartz50% | $30 → $22 | Maintains | Outperform | Get Alert |
| 02/24/2022 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 55.74% | Joseph Schwartz50% | $16 → $14 | Maintains | Outperform | Get Alert |
| 02/22/2022 | INSM | Buy Now | Insmed | $76.99 | -32.46% | Joseph Schwartz50% | $57 → $52 | Maintains | Outperform | Get Alert |
| 01/14/2022 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 77.99% | Joseph Schwartz50% | $12 → $16 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/16/2021 | TVTX | Buy Now | Travere Therapeutics | $20.12 | 108.75% | Joseph Schwartz50% | $37 → $42 | Maintains | Outperform | Get Alert |
| 12/14/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Joseph Schwartz50% | $112 → $100 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/10/2021 | RNA | Buy Now | Avidity Biosciences | $30.48 | 73.88% | Joseph Schwartz50% | $36 → $53 | Maintains | Outperform | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Joseph Schwartz50% | $282 → $35 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/22/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 60.73% | Joseph Schwartz50% | $112 → $115 | Maintains | Outperform | Get Alert |
| 11/16/2021 | SPRB | Buy Now | Spruce Biosciences | $0.33 | 1435.16% | Joseph Schwartz50% | $35 → $5 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/15/2021 | ASND | Buy Now | Ascendis Pharma | $164.65 | 15.4% | Joseph Schwartz50% | $182 → $190 | Maintains | Outperform | Get Alert |
| 11/15/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 56.53% | Joseph Schwartz50% | $108 → $112 | Maintains | Outperform | Get Alert |
| 11/11/2021 | SYBX | Buy Now | Synlogic | $1.29 | 752.71% | Joseph Schwartz50% | $225 → $165 | Maintains | Outperform | Get Alert |
| 11/09/2021 | GOSS | Buy Now | Gossamer Bio | $1.49 | 973.83% | Joseph Schwartz50% | $15 → $16 | Maintains | Outperform | Get Alert |
| 11/04/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.23 | 325.27% | Joseph Schwartz50% | $28 → $35 | Maintains | Outperform | Get Alert |
| 10/12/2021 | PTGX | Buy Now | Protagonist Therapeutics | $54.52 | -8.29% | Joseph Schwartz50% | $35 → $50 | Maintains | Outperform | Get Alert |
| 10/11/2021 | CCXI | Buy Now | ChemoCentryx | — | — | Joseph Schwartz50% | $17 → $64 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/30/2021 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 33.49% | Joseph Schwartz50% | $13 → $12 | Maintains | Market Perform | Get Alert |
| 09/20/2021 | PTGX | Buy Now | Protagonist Therapeutics | $54.52 | -35.8% | Joseph Schwartz50% | $50 → $35 | Maintains | Outperform | Get Alert |
| 08/26/2021 | ASND | Buy Now | Ascendis Pharma | $164.65 | 10.54% | Joseph Schwartz50% | $178 → $182 | Maintains | Outperform | Get Alert |
| 08/17/2021 | TVTX | Buy Now | Travere Therapeutics | $20.12 | 83.9% | Joseph Schwartz50% | $27 → $37 | Maintains | Outperform | Get Alert |
| 08/13/2021 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 1125.17% | Joseph Schwartz50% | $23 → $37 | Maintains | Outperform | Get Alert |
| 08/10/2021 | GOSS | Buy Now | Gossamer Bio | $1.49 | 906.71% | Joseph Schwartz50% | $19 → $15 | Maintains | Outperform | Get Alert |
| 08/05/2021 | PTGX | Buy Now | Protagonist Therapeutics | $54.52 | -8.29% | Joseph Schwartz50% | $41 → $50 | Maintains | Outperform | Get Alert |
| 07/21/2021 | ASND | Buy Now | Ascendis Pharma | $164.65 | 8.11% | Joseph Schwartz50% | $181 → $178 | Maintains | Outperform | Get Alert |
| 06/14/2021 | ASND | Buy Now | Ascendis Pharma | $164.65 | 9.93% | Joseph Schwartz50% | $191 → $181 | Maintains | Outperform | Get Alert |
| 05/07/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Joseph Schwartz50% | $90 → $112 | Maintains | Outperform | Get Alert |
| 05/07/2021 | CCXI | Buy Now | ChemoCentryx | — | — | Joseph Schwartz50% | $84 → $17 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/04/2021 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | Joseph Schwartz50% | → $250 | Initiates | → Outperform | Get Alert |
| 04/20/2021 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | 28.16% | Joseph Schwartz50% | → $34 | Initiates | → Outperform | Get Alert |
| 04/20/2021 | DSGN | Buy Now | Design Therapeutics | $4.81 | 648.44% | Joseph Schwartz50% | → $36 | Initiates | → Outperform | Get Alert |
| 03/22/2021 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 44.62% | Joseph Schwartz50% | $15 → $13 | Maintains | Market Perform | Get Alert |
| 03/16/2021 | SLDB | Buy Now | Solid Biosciences | $4.95 | 203.03% | Joseph Schwartz50% | $45 → $225 | Upgrade | Market Perform → Outperform | Get Alert |
| 03/08/2021 | IMRA | Buy Now | Imara | — | — | Joseph Schwartz50% | $236 → $168 | Maintains | Outperform | Get Alert |
| 03/03/2021 | PTGX | Buy Now | Protagonist Therapeutics | $54.52 | -24.8% | Joseph Schwartz50% | $30 → $41 | Maintains | Outperform | Get Alert |
| 03/02/2021 | PHVS | Buy Now | Pharvaris | $15.96 | 213.28% | Joseph Schwartz50% | → $50 | Initiates | → Outperform | Get Alert |
| 03/02/2021 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | 70.04% | Joseph Schwartz50% | $125 → $126 | Maintains | Outperform | Get Alert |
| 02/24/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Joseph Schwartz50% | $92 → $90 | Maintains | Outperform | Get Alert |
| 02/22/2021 | AMTI | Buy Now | Applied Molecular | — | — | Joseph Schwartz50% | $32 → $74 | Maintains | Outperform | Get Alert |
| 02/16/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 358.05% | Joseph Schwartz50% | $115 → $178 | Maintains | Outperform | Get Alert |
| 02/12/2021 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 66.87% | Joseph Schwartz50% | $30 → $15 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/10/2021 | KALV | Buy Now | KalVista Pharma | $12.47 | 308.98% | Joseph Schwartz50% | $39 → $51 | Maintains | Outperform | Get Alert |
| 01/27/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.23 | 240.22% | Joseph Schwartz50% | $24 → $28 | Maintains | Outperform | Get Alert |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | 68.69% | Joseph Schwartz50% | $197 → $125 | Maintains | Outperform | Get Alert |
| 01/04/2021 | INSM | Buy Now | Insmed | $76.99 | -28.56% | Joseph Schwartz50% | $51 → $55 | Maintains | Outperform | Get Alert |
| 12/14/2020 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 233.73% | Joseph Schwartz50% | $24 → $30 | Maintains | Outperform | Get Alert |
| 11/17/2020 | KALV | Buy Now | KalVista Pharma | $12.47 | 212.75% | Joseph Schwartz50% | $28 → $39 | Maintains | Outperform | Get Alert |
| 11/12/2020 | ASND | Buy Now | Ascendis Pharma | $164.65 | 16% | Joseph Schwartz50% | $173 → $191 | Maintains | Outperform | Get Alert |
| 11/10/2020 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 661.59% | Joseph Schwartz50% | $25 → $23 | Maintains | Outperform | Get Alert |
| 11/10/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Joseph Schwartz50% | $91 → $92 | Maintains | Outperform | Get Alert |
| 11/06/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 50.94% | Joseph Schwartz50% | $113 → $108 | Reiterates | → Outperform | Get Alert |
| 11/06/2020 | IFRX | Buy Now | InflaRx | $1.24 | 706.58% | Joseph Schwartz50% | $7 → $10 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/06/2020 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 166.98% | Joseph Schwartz50% | $19 → $24 | Maintains | Outperform | Get Alert |
| 11/06/2020 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | 165.86% | Joseph Schwartz50% | $214 → $197 | Maintains | Outperform | Get Alert |
| 11/03/2020 | SPRB | Buy Now | Spruce Biosciences | $0.33 | 10646.09% | Joseph Schwartz50% | → $35 | Initiates | → Outperform | Get Alert |
| 10/29/2020 | CCXI | Buy Now | ChemoCentryx | — | — | Joseph Schwartz50% | $75 → $84 | Maintains | Outperform | Get Alert |
| 10/28/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 195.93% | Joseph Schwartz50% | $110 → $115 | Maintains | Outperform | Get Alert |
| 10/13/2020 | GOSS | Buy Now | Gossamer Bio | $1.49 | 1846.31% | Joseph Schwartz50% | $36 → $29 | Maintains | Outperform | Get Alert |
| 10/07/2020 | KDNY | Buy Now | Chinook Therapeutics | — | — | Joseph Schwartz50% | → $38 | Initiates | → Outperform | Get Alert |
| 08/19/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 57.93% | Joseph Schwartz50% | $140 → $113 | Maintains | Outperform | Get Alert |
| 08/06/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Joseph Schwartz50% | $73 → $91 | Maintains | Outperform | Get Alert |
| 08/05/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 95.67% | Joseph Schwartz50% | $130 → $140 | Maintains | Outperform | Get Alert |
| 07/07/2020 | RNA | Buy Now | Avidity Biosciences | $30.48 | 18.11% | Joseph Schwartz50% | → $36 | Initiates | → Outperform | Get Alert |
| 06/30/2020 | AMTI | Buy Now | Applied Molecular | — | — | Joseph Schwartz50% | → $32 | Initiates | → Outperform | Get Alert |
| 06/12/2020 | IMRA | Buy Now | Imara | — | — | Joseph Schwartz50% | $108 → $256 | Maintains | Outperform | Get Alert |
| 05/22/2020 | PTGX | Buy Now | Protagonist Therapeutics | $54.52 | -44.97% | Joseph Schwartz50% | $17 → $30 | Maintains | Outperform | Get Alert |
| 05/20/2020 | ASND | Buy Now | Ascendis Pharma | $164.65 | 5.07% | Joseph Schwartz50% | $170 → $173 | Maintains | Outperform | Get Alert |
| 05/20/2020 | GOSS | Buy Now | Gossamer Bio | $1.49 | 2316.11% | Joseph Schwartz50% | $27 → $36 | Reiterates | → Outperform | Get Alert |
| 05/12/2020 | CCXI | Buy Now | ChemoCentryx | — | — | Joseph Schwartz50% | $54 → $65 | Reiterates | → Outperform | Get Alert |
| 05/08/2020 | IMRA | Buy Now | Imara | — | — | Joseph Schwartz50% | $100 → $108 | Reiterates | → Outperform | Get Alert |
| 05/07/2020 | IFRX | Buy Now | InflaRx | $1.24 | 464.61% | Joseph Schwartz50% | $4 → $7 | Maintains | Market Perform | Get Alert |
| 04/20/2020 | ASND | Buy Now | Ascendis Pharma | $164.65 | 3.25% | Joseph Schwartz50% | $152 → $170 | Maintains | Outperform | Get Alert |
| 04/06/2020 | IMRA | Buy Now | Imara | — | — | Joseph Schwartz50% | → $100 | Initiates | → Outperform | Get Alert |
| 08/19/2019 | SLDB | Buy Now | Solid Biosciences | $4.95 | — | Joseph Schwartz50% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 03/05/2019 | GOSS | Buy Now | Gossamer Bio | $1.49 | — | Joseph Schwartz50% | — | Initiates | → Outperform | Get Alert |
| 01/24/2019 | ASND | Buy Now | Ascendis Pharma | $164.65 | -45.34% | Joseph Schwartz50% | $73 → $90 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/19/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 144.47% | Joseph Schwartz50% | $68 → $95 | Maintains | Outperform | Get Alert |
| 06/20/2018 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | 164.51% | Joseph Schwartz50% | $121 → $196 | Maintains | Outperform | Get Alert |
| 03/13/2018 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | 24.16% | Joseph Schwartz50% | $79 → $92 | Maintains | Outperform | Get Alert |
| 02/23/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 84.49% | Joseph Schwartz50% | $142 → $132 | Maintains | Outperform | Get Alert |
| 02/08/2018 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 166.98% | Joseph Schwartz50% | $20 → $24 | Maintains | Outperform | Get Alert |
| 01/05/2018 | RGLS | Buy Now | Regulus Therapeutics | $1.33 | 50.38% | Joseph Schwartz50% | → $240 | Initiates | → Outperform | Get Alert |
| 12/12/2017 | ONCE | Buy Now | Spark Therapeutics | — | — | Joseph Schwartz50% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/23/2017 | NITE | Buy Now | Nightstar Therapeutics plc - American Depositary Shares | $26.21 | -4.6% | Joseph Schwartz50% | → $25 | Initiates | → Outperform | Get Alert |
| 10/23/2017 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.23 | 70.11% | Joseph Schwartz50% | $10 → $14 | Maintains | Outperform | Get Alert |
| 10/19/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 98.46% | Joseph Schwartz50% | $136 → $142 | Maintains | Outperform | Get Alert |
| 09/26/2017 | PRQR | Buy Now | ProQR Therapeutics | $1.71 | 601.75% | Joseph Schwartz50% | $10 → $12 | Maintains | Outperform | Get Alert |
| 09/19/2017 | SYBX | Buy Now | Synlogic | $1.29 | 1837.98% | Joseph Schwartz50% | → $375 | Initiates | → Outperform | Get Alert |
| 09/13/2017 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Joseph Schwartz50% | → $43 | Initiates | → Outperform | Get Alert |
| 08/28/2017 | CMTA | Buy Now | Clementia Pharmaceuticals Inc. - Common Shares | — | — | Joseph Schwartz50% | → $23 | Initiates | → Outperform | Get Alert |
| 05/19/2017 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Joseph Schwartz50% | → $500 | Initiates | → Outperform | Get Alert |
| 05/18/2017 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | Joseph Schwartz50% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 03/09/2017 | ASND | Buy Now | Ascendis Pharma | $164.65 | -81.78% | Joseph Schwartz50% | $24 → $30 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/02/2017 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | -36.57% | Joseph Schwartz50% | $27 → $47 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/09/2017 | ONCE | Buy Now | Spark Therapeutics | — | — | Joseph Schwartz50% | → $85 | Initiates | → Outperform | Get Alert |
| 05/04/2016 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | Joseph Schwartz50% | $7 → $9 | Maintains | Market Perform | Get Alert |
| 05/02/2016 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | -93.25% | Joseph Schwartz50% | $13 → $5 | Downgrade | Market Perform → Underperform | Get Alert |
| 02/23/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 67.71% | Joseph Schwartz50% | $149 → $120 | Maintains | Outperform | Get Alert |
| 02/19/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 105.87% | Joseph Schwartz50% | → $80 | Initiates | → Outperform | Get Alert |
| 01/29/2016 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | Joseph Schwartz50% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/06/2015 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | -63.56% | Joseph Schwartz50% | $33 → $27 | Maintains | Market Perform | Get Alert |
| 10/05/2015 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 133.61% | Joseph Schwartz50% | $23 → $21 | Maintains | Outperform | Get Alert |
| 03/04/2015 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 44.62% | Joseph Schwartz50% | $9 → $13 | Maintains | Outperform | Get Alert |
| 02/23/2015 | ASND | Buy Now | Ascendis Pharma | $164.65 | -81.78% | Joseph Schwartz50% | → $30 | Initiates | → Outperform | Get Alert |
| 02/02/2015 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.23 | -2.79% | Joseph Schwartz50% | → $8 | Initiates | → Outperform | Get Alert |
| 10/13/2014 | PRQR | Buy Now | ProQR Therapeutics | $1.71 | 1303.51% | Joseph Schwartz50% | → $24 | Initiates | → Outperform | Get Alert |
| 07/01/2014 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | -33.25% | Joseph Schwartz50% | $2.5 → $6 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/12/2013 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | -77.06% | Joseph Schwartz50% | $44 → $17 | Maintains | Market Perform | Get Alert |
| 10/24/2013 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | — | Joseph Schwartz50% | — | Downgrade | → Market Perform | Get Alert |
| 04/16/2013 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | — | Joseph Schwartz50% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/05/2013 | SRPT | Buy Now | Sarepta Therapeutics | $74.10 | -39.27% | Joseph Schwartz50% | → $45 | Initiates | → Outperform | Get Alert |
| 02/06/2013 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Joseph Schwartz50% | — | Assumes | → Outperform | Get Alert |
